aminoglutethimide has been researched along with Fibrous Dysplasia, Polyostotic in 2 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Fibrous Dysplasia, Polyostotic: FIBROUS DYSPLASIA OF BONE affecting several bones. When melanotic pigmentation (CAFE-AU-LAIT SPOTS) and multiple endocrine hyperfunction are additionally associated it is referred to as Albright syndrome.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vong, CH | 1 |
Forest, M | 1 |
Nicolino, M | 1 |
Gillis, D | 1 |
Rösler, A | 1 |
Hannon, TS | 1 |
Koplewitz, BZ | 1 |
Hirsch, HJ | 1 |
2 other studies available for aminoglutethimide and Fibrous Dysplasia, Polyostotic
Article | Year |
---|---|
Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
Topics: Adrenergic Agents; Adrenocorticotropic Hormone; Aminoglutethimide; Antifungal Agents; Chemical and D | 2009 |
Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome.
Topics: Adrenalectomy; Adrenergic Agents; Aminoglutethimide; Child; Cushing Syndrome; Enzyme Inhibitors; Fem | 2008 |